{
    "answer": "For full year 2024: Cosentyx's immunology segment reported net sales were $1.6 billion, which grew 10% to $1.7 billion in constant currency, while the immunology segment sales were $16.4 billion, with $1.6 billion from Cosentyx. For full year 2023: Cosentyx's immunology segment reported net sales were $1.2 billion, which grew 56% to $1.7 billion in constant currency, while the immunology segment sales were $12.8 billion, with $1.2 billion from Cosentyx.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        923,
        2422,
        3927,
        5654,
        7235
    ]
}